BioVectra

Biovectra manufacturing

Pharma

Agilent will pay $925M to acquire specialty CDMO Biovectra

After changing hands several times throughout the 2010s, Canadian specialty CDMO Biovectra has agreed to fly the Agilent flag.

Fraiser Kansteiner Jul 22, 2024 11:01am

Mallinckrodt

Mallinckrodt unloads its CDMO for $250M as potential liabilities mount

Sep 10, 2019 10:34am

BioVectra illustration

Mallinckrodt invests $100M in its BioVectra CDMO

Mar 6, 2019 12:36pm